Journal article icon

Journal article

Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomised controlled trials

Abstract:
Background
Platelet dysfunction, including that caused by antiplatelet agents, increases the risk of peri-operative bleeding. The optimal management of patients with platelet dysfunction undergoing surgery is unclear.

Objectives
To assess whether desmopressin reduces peri-operative allogeneic red cell transfusion and bleeding for patients with platelet dysfunction.

Patients/Methods
We searched for randomised controlled trials in The Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, Embase, the Transfusion Evidence Library and ISI Web of Science to 7th July 2016. Data were pooled using mean difference (MD), relative risks or Peto odds ratios (pOR) using a random-effects model.

Results
Ten trials with 596 participants were identified, all in the setting of cardiac surgery. Platelet dysfunction was due to antiplatelet agents in six trials and cardiopulmonary bypass in four trials. Patients treated with desmopressin were transfused with fewer red cells (MD -0.65 units, 95% CI -1.16 to -0.13); lost less blood (MD -253.93 ml, 95% CI -408.01 to -99.85 ml); and had a lower risk of re-operation due to bleeding (pOR 0.39, 95% CI 0.18 to 0.84). Similar results were found for the subgroups with platelet dysfunction due to antiplatelet agents or other causes, with little evidence of statistical heterogeneity between subgroups. The GRADE quality of evidence was very low to moderate suggesting considerable uncertainty over the results

Conclusions
Desmopressin may be a useful agent to reduce bleeding and transfusion requirements for people with platelet dysfunction or with a history of recent anti-platelet drug administration undergoing surgery.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/jth.13576

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author


Publisher:
Wiley
Journal:
Journal of Thrombosis and Haemostasis More from this journal
Volume:
15
Issue:
2
Pages:
263–272
Publication date:
2017-02-08
Acceptance date:
2016-11-19
DOI:
EISSN:
1538-7836
ISSN:
1538-7933


Keywords:
Pubs id:
pubs:660486
UUID:
uuid:97c1f569-c6e3-4645-8e21-4f54f6c33b49
Local pid:
pubs:660486
Source identifiers:
660486
Deposit date:
2016-11-21
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP